BIO Bio-Rad Laboratories Inc

$309.24

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/6/2025

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.

Website: https://www.bio-rad.com

Sector
LIFE SCIENCES
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
12208
Address
1000 ALFRED NOBEL DRIVE, HERCULES, CA, US
Valuation
Market Cap
$6.69B
P/E Ratio
nan
PEG Ratio
1.19
Price to Book
1.02
Performance
EPS
$-65.36
Dividend Yield
Profit Margin
-71.90%
ROE
-24.10%
Technicals
50D MA
$262.49
200D MA
$314.69
52W High
$387.99
52W Low
$215.38
Fundamentals
Shares Outstanding
23M
Target Price
$353.17
Beta
1.12

BIO EPS Estimates vs Actual

Estimated
Actual

BIO News & Sentiment

Sep 24, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando
NASHVILLE, Tenn., Sept. 24, 2025 ( GLOBE NEWSWIRE ) -- Insight Molecular Diagnostics Inc., ( Nasdaq: IMDX ) , ( iMDx ) , today announced attendance at two key industry conferences where it will discuss its GraftAssure™ technology, including its clinical kitted test under development.
Sep 24, 2025 • Benzinga NEUTRAL
Insight Molecular Diagnostics to Showcase Leadership in Kidney Transplant Management at Conferences in Singapore and Orlando - ( IMDX )
IMDX to host symposium on Wednesday, September 24th to discuss GraftAssureIQ™ at International Association of Therapeutic Drug Monitoring and Clinical Toxicology ( IATDMCT ) annual meeting
Sep 23, 2025 • Benzinga SOMEWHAT-BULLISH
Chromatography Technologies Powering the Future of Biopharmaceuticals
Boston, Sept. 23, 2025 ( GLOBE NEWSWIRE ) -- According to the latest study from BCC Research, the "Chromatography in Pharmaceuticals and Biotechnology: Global Markets" is projected to grow from $13.3 billion in 2025 to $19.8 billion by the end of 2030, at a compound annual growth rate ( CAGR ) ...
Sep 01, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is it Apt to Hold Bio-Rad Stock in Your Portfolio Now?
BIO's strong ddPCR growth and solid diagnostics demand support its stock despite market pressures and stiff competition.
Aug 25, 2025 • Benzinga SOMEWHAT-BULLISH
[Latest] Global Chemical Reagents Market Size/Share Worth USD 26.5 Billion by 2034 at a 7.5 CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis )
Austin, TX, USA, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "Chemical Reagents Market Size, Trends and Insights By Product Type ( Solvents, Acids & Bases, Oxidizing & Reducing Agents, Buffers & Standards, Catalysts ) , By Application ( ...
Aug 08, 2025 • Benzinga BULLISH
Baculovirus Expression System Market Poised for Significant Growth, Estimate to Hit USD 781.8 Million by 2032 | Coherent Market Insights
Burlingame, CA, Aug. 08, 2025 ( GLOBE NEWSWIRE ) -- The global Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn in 2032, exhibiting a compound annual growth rate ( CAGR ) of 8.7% from 2025 to 2032.
Sentiment Snapshot

Average Sentiment Score:

0.138
50 articles with scored sentiment

Overall Sentiment:

Neutral

BIO Reported Earnings

May 05, 2025
Mar 31, 2025 (Post market)
0.76 Surprise
  • Reported EPS: $2.54
  • Estimate: $1.78
  • Whisper:
  • Surprise %: 42.5%
Feb 13, 2025
Dec 31, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $2.90
  • Estimate: $2.88
  • Whisper:
  • Surprise %: 0.6%
Oct 30, 2024
Sep 30, 2024 (Post market)
0.85 Surprise
  • Reported EPS: $2.01
  • Estimate: $1.16
  • Whisper:
  • Surprise %: 73.3%
Aug 01, 2024
Jun 30, 2024 (Post market)
1.1 Surprise
  • Reported EPS: $3.11
  • Estimate: $2.01
  • Whisper:
  • Surprise %: 54.7%
May 07, 2024
Mar 31, 2024 (Post market)
0.14 Surprise
  • Reported EPS: $2.29
  • Estimate: $2.15
  • Whisper:
  • Surprise %: 6.5%
Feb 15, 2024
Dec 31, 2023 (Post market)
0.28 Surprise
  • Reported EPS: $3.10
  • Estimate: $2.82
  • Whisper:
  • Surprise %: 9.9%
Oct 26, 2023
Sep 30, 2023 (Post market)
-0.45 Surprise
  • Reported EPS: $2.33
  • Estimate: $2.78
  • Whisper:
  • Surprise %: -16.2%
Aug 03, 2023
Jun 30, 2023 (Post market)
0.32 Surprise
  • Reported EPS: $3.00
  • Estimate: $2.68
  • Whisper:
  • Surprise %: 11.9%
May 04, 2023
Mar 31, 2023 (Post market)
-0.2 Surprise
  • Reported EPS: $3.34
  • Estimate: $3.54
  • Whisper:
  • Surprise %: -5.7%

Financials